Hindié E - Search Results

1

Modern nuclear imaging for paragangliomas: beyond SPECT.

Taïeb D, Neumann H, Rubello D, Al-Nahhas A, Guillet B, Hindié E. Taïeb D, et al. Among authors: hindie e. J Nucl Med. 2012 Feb;53(2):264-74. doi: 10.2967/jnumed.111.098152. J Nucl Med. 2012. PMID: 22302963 Free article. Review.

2

Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications.

Taïeb D, Hassad R, Sebag F, Colavolpe C, Guedj E, Hindié E, Henry JF, Mundler O. Taïeb D, et al. Among authors: hindie e. J Nucl Med Technol. 2007 Sep;35(3):135-9. doi: 10.2967/jnmt.107.039743. Epub 2007 Aug 16. J Nucl Med Technol. 2007. PMID: 17702904 Free article.

3

Distant metastases of differentiated thyroid cancer: diagnosis, treatment and outcome.

Toubert ME, Hindie E, Rampin L, Al-Nahhas A, Rubello D. Toubert ME, et al. Among authors: hindie e. Nucl Med Rev Cent East Eur. 2007;10(2):106-9. Nucl Med Rev Cent East Eur. 2007. PMID: 18228215 Review.

4

Overview on the use of recombinant human thyrotropin in thyroid cancer of follicular cell origin.

Zanotti-Fregonara P, Toubert ME, Taieb D, Ravasi L, Rubello D, Hindie E. Zanotti-Fregonara P, et al. Among authors: hindie e. Minerva Endocrinol. 2008 Jun;33(2):53-65. Epub 2008 Mar 11. Minerva Endocrinol. 2008. PMID: 18332849 Free article. Review.

5

Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective.

Zanotti-Fregonara P, Rubello D, Hindié E. Zanotti-Fregonara P, et al. Among authors: hindie e. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1397-9. doi: 10.1007/s00259-008-0823-0. Epub 2008 May 10. Eur J Nucl Med Mol Imaging. 2008. PMID: 18470514 No abstract available.

6

Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Hindié E, Champion C, Zanotti-Fregonara P, Rubello D, Colas-Linhart N, Ravasi L, Moretti JL. Hindié E, et al. Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):130-6. doi: 10.1007/s00259-008-0893-z. Epub 2008 Aug 9. Eur J Nucl Med Mol Imaging. 2009. PMID: 18690435

7

Slow dynamic lymphoscintigraphy is not a reliable predictor of sentinel-node negativity in cutaneous melanoma.

Toubert ME, Just PA, Baillet G, Kerob D, Hindié E, Verola O, Revol M, Servant JM, Basset-Seguin N, Lebbé C, Banti E, Rubello D, Moretti JL. Toubert ME, et al. Among authors: hindie e. Cancer Biother Radiopharm. 2008 Aug;23(4):443-50. doi: 10.1089/cbr.2008.0468. Cancer Biother Radiopharm. 2008. PMID: 18771348

8

A low thyroglobulin level cannot be used to avoid adjuvant 131I therapy after thyroidectomy for thyroid carcinoma.

Zanotti-Fregonara P, Grassetto G, Hindié E, Rubello D. Zanotti-Fregonara P, et al. Among authors: hindie e. Eur J Nucl Med Mol Imaging. 2009 Feb;36(2):169-71. doi: 10.1007/s00259-008-0963-2. Eur J Nucl Med Mol Imaging. 2009. PMID: 18850097 No abstract available.

9

Bone metastases of differentiated thyroid cancer: the importance of early diagnosis and 131I therapy on prognosis.

Zanotti-Fregonara P, Rubello D, Hindié E. Zanotti-Fregonara P, et al. Among authors: hindie e. J Nucl Med. 2008 Nov;49(11):1902-3. doi: 10.2967/jnumed.108.054163. Epub 2008 Oct 16. J Nucl Med. 2008. PMID: 18927327 Free article. No abstract available.

10

What role for recombinant human TSH in the treatment of metastatic thyroid cancer?

Zanotti-Fregonara P, Hindié E, Toubert ME, Rubello D. Zanotti-Fregonara P, et al. Among authors: hindie e. Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):883-5. doi: 10.1007/s00259-008-1046-0. Eur J Nucl Med Mol Imaging. 2009. PMID: 19153732 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters